
Edwards Lifesciences Corp
EW · NYSE · Healthcare / Medical Devices
Price History
Full chartMarket Stats
About
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Company Details
- SectorHealthcare
- IndustryMedical Devices
- CEOMr. Bernard J. Zovighian
- Employees16.00K
- HeadquartersOne Edwards Way, Irvine, CA, United States, 92614, USA
- Websitehttps://www.edwards.com
Leadership
- Mr. Bernard J. ZovighianCEO & Director · b. 1968
- Mr. Donald E. Bobo Jr.Corporate Vice President of Strategy & Corporate Development · b. 1962
- Mr. Daveen ChopraCorporate Vice President of Transcatheter Mitral & Tricuspid Therapies · b. 1979
- Ms. Annette Maria BrulsCorporate Vice President of EMEA, Canada, & Latin America · b. 1971
- Ms. Theodora MistrasCorporate VP & CFO · b. 1982
- Mr. Joseph NuzzoleseCorporate Vice President of Global Operations & Quality
- Mr. Andrew M. DahlPrincipal Accounting Officer, Senior VP & Corporate Controller · b. 1978
- Dr. Todd Brinton FACC, M.D.Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer
- Mr. Snehashish SarkarSenior VP and Chief Information & Digital Officer · b. 1975
- Mr. Mark D. PetersonCorporate VP & General Counsel · b. 1963
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Strong Buy18
- Buy5
- Hold7
Ownership Breakdown
- Institutions
- 95.67%
- Insiders
- 0.19%
- Retail / Other
- 4.14%
Top Institutional Holders
- BlackRock Inc58.79M10.20%
- Vanguard Capital Management, LLC37.62M6.53%
- Vanguard Portfolio Management, LLC26.41M4.58%
- State Street Corp26.32M4.57%
- JPMorgan Chase & Co22.78M3.95%
- Wellington Management Company LLP16.83M2.92%
- Geode Capital Management, LLC15.44M2.68%
- Bank of New York Mellon Corp14.08M2.44%
- DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main13.00M2.26%
- Ninety One UK Limited12.34M2.14%
- Aristotle Capital Management LLC8.67M1.50%
- AllianceBernstein L.P.8.66M1.50%
- FMR Inc8.44M1.46%
- NORGES BANK8.37M1.45%
Top Fund Holders
- Vanguard MStar Total Stk Mkt Idx Invest18.28M3.17%
- Vanguard 500 Index Investor15.14M2.63%
- Vanguard MStar Mid Cap Index Instl12.34M2.14%
- Vanguard Health Care Inv10.69M1.85%
- iShares Core S&P 500 ETF7.68M1.33%
- Fidelity 500 Index7.47M1.30%
Stock Splits
- Jun 1, 20203:1
- Dec 14, 20152:1
- May 28, 20102:1